141 related articles for article (PubMed ID: 8886889)
1. Protective effect of NG-monomethyl-L-arginine against hypotension inducted by combined tumour necrosis factor-alpha and whole body hyperthermia in rats.
Makino M; Lodato RF; Stephens LC; Strebel FR; Jenkins G; Ohno S; Sakaguchi Y; Kostergaard J; Tomasovic SP; Bull JM
Int J Hyperthermia; 1996; 12(5):617-34. PubMed ID: 8886889
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats.
Sakaguchi Y; Makino M; Kaneko T; Stephens LC; Strebel FR; Danhauser LL; Jenkins GN; Bull JM
Cancer Res; 1994 Apr; 54(8):2223-7. PubMed ID: 8174130
[TBL] [Abstract][Full Text] [Related]
3. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
Ohno S; Strebel FR; Stephens LC; Siddik ZH; Makino M; Klostergaard J; Tomasovic SP; Khokhar AR; Bull JM
Cancer Res; 1992 Aug; 52(15):4096-101. PubMed ID: 1638521
[TBL] [Abstract][Full Text] [Related]
4. Effect of nitric oxide on mortality of mice after whole body hyperthermia.
Poduval TB; Chatterjee S; Sainis KB
Int J Hyperthermia; 2003; 19(1):35-44. PubMed ID: 12519710
[TBL] [Abstract][Full Text] [Related]
5. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.
Kilbourn RG; Gross SS; Jubran A; Adams J; Griffith OW; Levi R; Lodato RF
Proc Natl Acad Sci U S A; 1990 May; 87(9):3629-32. PubMed ID: 2333306
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic high-dose N(omega)-monomethyl-L-arginine prevents the late cardiac dysfunction associated with lethal tumor necrosis factor-alpha challenge in dogs.
Sevransky J; Vandivier RW; Gerstenberger E; Correa R; Ferantz V; Banks SM; Danner RL; Eichacker PQ; Natanson C
Shock; 2005 Mar; 23(3):281-8. PubMed ID: 15718929
[TBL] [Abstract][Full Text] [Related]
7. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
Ohno S; Siddik ZH; Baba H; Stephens LC; Strebel FR; Wondergem J; Khokhar AR; Bull JM
Cancer Res; 1991 Jun; 51(11):2994-3000. PubMed ID: 2032236
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
Robins HI; Katschinski DM; Longo W; Grosen E; Wilding G; Gillis W; Kraemer C; Tiggelaar CL; Rushing D; Stewart JA; Spriggs D; Love R; Arzoomanian RZ; Feierabend C; Alberti D; Morgan K; Simon K; d'Oleire F
Cancer Chemother Pharmacol; 1999; 43(5):409-14. PubMed ID: 10100597
[TBL] [Abstract][Full Text] [Related]
9. Optimal duration of whole body hyperthermia when combined with cis-diaminne-1,1-cychlobutane dicarboxylate platinum (II) (carboplatin).
Kaneko T; Sakaguchi Y; Makino M; Matsuda H; Strebel FR; Jenkins GN; Bull JM
Anticancer Res; 1997; 17(3C):1897-901. PubMed ID: 9216642
[TBL] [Abstract][Full Text] [Related]
10. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats.
Wang D; Wei J; Hsu K; Jau J; Lieu MW; Chao TJ; Chen HI
J Biomed Sci; 1999 Jan; 6(1):28-35. PubMed ID: 9933740
[TBL] [Abstract][Full Text] [Related]
11. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase inhibition increases venular leukocyte rolling and adhesion in septic rats.
Sundrani R; Easington CR; Mattoo A; Parrillo JE; Hollenberg SM
Crit Care Med; 2000 Aug; 28(8):2898-903. PubMed ID: 10966268
[TBL] [Abstract][Full Text] [Related]
13. The effect of the nitric oxide synthesis inhibitor L-NAME on amitriptyline-induced hypotension in rats.
Tuncok Y; Kalkan S; Murat N; Arkan F; Guven H; Aygoren O; Kurt S
J Toxicol Clin Toxicol; 2002; 40(2):121-7. PubMed ID: 12126183
[TBL] [Abstract][Full Text] [Related]
14. Effect of endogenous nitric oxide on tumour necrosis factor-alpha-induced leukosequestration and IL-8 release in guinea-pigs airways in vivo.
Kuo HP; Hwang KH; Lin HC; Wang CH; Lu LC
Br J Pharmacol; 1997 Sep; 122(1):103-11. PubMed ID: 9298535
[TBL] [Abstract][Full Text] [Related]
15. Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine.
Kilbourn RG; Fonseca GA; Trissel LA; Griffith OW
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S21-30. PubMed ID: 10685654
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide inhibition attenuates systemic hypotension produced by protamine.
Raikar GV; Hisamochi K; Raikar BL; Schaff HV
J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1240-6; discussion 1246-7. PubMed ID: 8642826
[TBL] [Abstract][Full Text] [Related]
19. Whole-body hyperthermia combined with ifosfamide and carboplatin causes hypotension and nephrotoxicity.
Brauer LP; Prieshof B; Wiedemann GJ; Weiss C; Kriz W; Schramm U; Robins HI; Pagel H
J Cancer Res Clin Oncol; 1998; 124(10):549-54. PubMed ID: 9829858
[TBL] [Abstract][Full Text] [Related]
20. Effects of isoprostane on tubuloglomerular feedback: roles of TP receptors, NOS, and salt intake.
Welch WJ
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F757-62. PubMed ID: 15613618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
